Science decoded, the business angle included.
Ingredient markets, clinical studies under scrutiny, regulatory, AI visibility. Every insight is sourced — PubMed, EFSA, dated reports — and ends with what it changes for your pipeline.
-1.jpg)
Fermented Foods in Europe: A Two-Speed Market
The PIMENTO mapping study of 12,646 Europeans reveals a gap between marketing hype and actual volumes for fermented foods in Europe.
Sulforaphane: Conversion Outside the Body Changes the Game
Vibe coding: what an ingredient team can build
Health claims: one evidence base for 5 documents
Technical data sheet, one-pager, deck, website, health claim dossier: one study lives in five files. A single evidence base stops them drifting apart.
Read the insight
Wellness 2027: your ingredients in a system, not a product
Mintel announces the Products to Systems shift: why your ingredients within a wellness system are worth more than a standalone active by 2027.
Read the insight
AI hallucinations: 5 tasks to keep in a health claim dossier
AI hallucinations and health claims: invented references, reworded claims, exposed trial data. Five dossier tasks AI must not do alone, and those it speeds up.
Read the insight
Scientific and regulatory monitoring: 3 streams to automate
Scientific and regulatory monitoring: PubMed indexed 9,612 papers on biotics in 2025, 347 of them randomised trials. Automating means sorting first.
Read the insight
Whey shortage: rethinking protein sourcing for 2026
The whey shortage is driving sports protein prices sharply higher. How to diversify your sourcing and secure your supply chains without compromising amino acid quality.
Read the insight
How to choose a B2B marketing agency for nutrition and ingredients
Your buyers ask an AI before they talk to a salesperson. The right B2B nutrition agency is no longer the one with the finest portfolio, but the one that makes you citable and scientifically credible. The five criteria.
Read the insight
Made in EU label: the key to the Chinese market in 2026
The world’s second-largest nutraceuticals market, worth USD 17 billion, with 51 per cent of Q3 sales made online: ‘Made in the EU’ is opening the door to the Chinese market. The label alone is not enough to win over consumers.
Read the insight
FDA GRAS overhaul: what awaits US-bound suppliers
In brief — The FDA wants to make GRAS notifications, currently voluntary, mandatory. A fragile legal basis since the Loper Bright ruling (2024): what ingredient suppliers targeting the United States are risking.
Read the insight
Carob flour: the texture lever for gluten-free pasta
In brief — Substituting 20% of a chickpea-teff base with carob flour raises fibre by 51%, cuts starch digestibility by 28% and lifts post-cooking firmness from 3.08 N to 4.83 N (Frontiers in Nutrition, 2026).
Read the insight